Search Results - Jacques Delaunay
- Showing 1 - 20 results of 20
-
1
-
2
-
3
-
4
-
5
Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia by Thomas Prebet, Sarah Bertoli, Jacques Delaunay, Arnaud Pigneux, Eric Delabesse, Marie Joelle Mozziconacci, Audrey Bidet, Christian Recher, Norbert Vey
Published in Haematologica (2014-10-01)Get full text
Article -
6
Continuous Blood Pressure Monitoring in Daily Life by Guillaume LOPEZ, Masaki SHUZO, Hiroyuki USHIDA, Keita HIDAKA, Shintaro YANAGIMOTO, Yasushi IMAI, Akio KOSAKA, Jean-Jacques DELAUNAY, Ichiro YAMADA
Published in Journal of Advanced Mechanical Design, Systems, and Manufacturing (2010-02-01)Get full text
Article -
7
-
8
Multiple brain lesions in a patient with relapsed hairy cell leukemia: a case report and review of the literature by Katell Le Dû, Jacques Delaunay, Maud Voldoire, Thomas Cuvier, Pierre-Yves Renard, Benoît Quilichini, Eric Wafflart, Julien Dubreuil, Sophie Sadot-Lebouvier
Published in CNS Oncology (2025-12-01)Get full text
Article -
9
A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe... by Lionel Ades, Agnès Guerci-Bresler, Pascale Cony-Makhoul, Laurence Legros, Marie Sebert, Thorsten Braun, Jacques Delaunay, Kristell Desseaux, Sylvie Chevret, Pierre Fenaux
Published in Haematologica (2019-04-01)Get full text
Article -
10
The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features by Marion Eveillard, Jacques Delaunay, Steven Richebourg, Laurence Lodé, Richard Garand, Soraya Wuillème, François Duhoux, Hélène Antoine-Poirel, Catherine Godon, Marie C. Béné
Published in Haematologica (2015-03-01)Get full text
Article -
11
Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies by Claire Oudin, Patrice Chevallier, Sabine Furst, Thierry Guillaume, Jean El Cheikh, Jacques Delaunay, Luca Castagna, Catherine Faucher, Angela Granata, Raynier Devillier, Christian Chabannon, Benjamin Esterni, Norbert Vey, Mohamad Mohty, Didier Blaise
Published in Haematologica (2014-11-01)Get full text
Article -
12
Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study by Patrice Chevallier, Francoise Huguet, Emmanuel Raffoux, Anne Etienne, Thibaut Leguay, Francoise Isnard, Nelly Robillard, Thierry Guillaume, Jacques Delaunay, Aude Charbonnier, Arnaud Pigneux, Pierre Peterlin, Marie C. Bené, William A. Wegener, David M. Goldenberg, Hervé Dombret
Published in Haematologica (2015-04-01)Get full text
Article -
13
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial by Patrice Chevallier, Myriam Labopin, Gérard Socié, Reza Tabrizi, Sabine Furst, Bruno Lioure, Thierry Guillaume, Jacques Delaunay, Régis Peffault de La Tour, Stéphane Vigouroux, Jean El-Cheikh, Didier Blaise, Mauricette Michallet, Karin Bilger, Noel Milpied, Philippe Moreau, Mohamad Mohty
Published in Haematologica (2014-09-01)Get full text
Article -
14
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Franc... by Lionel Adès, Fabien Le Bras, Marie Sebert, Charikleia Kelaidi, Thierry Lamy, François Dreyfus, Virginie Eclache, Jacques Delaunay, Didier Bouscary, Sorin Visanica, Pascal Turlure, Agnès Guerci Bresler, Marie-Paule Cabrol, Anne Banos, Michel Blanc, Norbert Vey, Alain Delmer, Eric Wattel, Sylvie Chevret, Pierre Fenaux
Published in Haematologica (2012-02-01)Get full text
Article -
15
Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide by Laurence Lodé, Audrey Ménard, Laurent Flet, Steven Richebourg, Marion Loirat, Marion Eveillard, Yannick Le Bris, Catherine Godon, Olivier Theisen, Anne-Laure Gagez, Guillaume Cartron, Thérèse Commes-Maerten, Bruno Villemagne, Odile Luycx, Pascal Godmer, Catherine Pellat-Deceunynck, Thierry Soussi, Marie C. Béné, Jacques Delaunay, Pierre Peterlin
Published in Haematologica (2018-04-01)Get full text
Article -
16
Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies by Charikleia Kelaidi, Aspasia Stamatoullas, Odile Beyne-Rauzy, Emmanuel Raffoux, Bruno Quesnel, Agnes Guerci, François Dreyfus, Sabine Brechignac, Christian Berthou, Thomas Prebet, Yosr Hicheri, Maya Hacini, Jacques Delaunay, Marie-Pierre Gourin, Jean-Marie Camo, Hacene Zerazhi, Anne-Laure Taksin, Laurence Legros, Bachra Choufi, Pierre Fenaux
Published in Haematologica (2010-06-01)Get full text
Article -
17
Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter... by Sarah Bertoli, Pierre Bories, Marie C. Béné, Sylvie Daliphard, Bruno Lioure, Arnaud Pigneux, Norbert Vey, Jacques Delaunay, Vincent Leymarie, Isabelle Luquet, Odile Blanchet, Pascale Cornillet-Lefebvre, Mathilde Hunault, Didier Bouscary, Nathalie Fegueux, Philippe Guardiola, François Dreyfus, Jean Luc Harousseau, Jean Yves Cahn, Norbert Ifrah, Christian Récher
Published in Haematologica (2014-01-01)Get full text
Article -
18
A randomized phase II trial of azacitidine +/− epoetin-β in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents by Sylvain Thépot, Raouf Ben Abdelali, Sylvie Chevret, Aline Renneville, Odile Beyne-Rauzy, Thomas Prébet, Sophie Park, Aspasia Stamatoullas, Agnes Guerci-Bresler, Stéphane Cheze, Gérard Tertian, Bachra Choufi, Laurence Legros, Jean Noel Bastié, Jacques Delaunay, Marie Pierre Chaury, Laurence Sanhes, Eric Wattel, Francois Dreyfus, Norbert Vey, Fatiha Chermat, Claude Preudhomme, Pierre Fenaux, Claude Gardin
Published in Haematologica (2016-08-01)Get full text
Article -
19
Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients by Véronique Picard, Corinne Guitton, Isabelle Thuret, Christian Rose, Laurence Bendelac, Kaldoun Ghazal, Patricia Aguilar-Martinez, Catherine Badens, Claire Barro, Claire Bénéteau, Claire Berger, Pascal Cathébras, Eric Deconinck, Jacques Delaunay, Jean-Marc Durand, Nadia Firah, Frédéric Galactéros, Bertrand Godeau, Xavier Jaïs, Jean-Pierre de Jaureguiberry, Camille Le Stradic, François Lifermann, Robert Maffre, Gilles Morin, Julien Perrin, Valérie Proulle, Marc Ruivard, Fabienne Toutain, Agnès Lahary, Loïc Garçon
Published in Haematologica (2019-08-01)Get full text
Article -
20
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study by Sophie Vantyghem, Pierre Peterlin, Sylvain Thépot, Audrey Ménard, Viviane Dubruille, Camille Debord, Thierry Guillaume, Alice Garnier, Amandine Le Bourgeois, Soraya Wuilleme, Catherine Godon, Olivier Theisen, Marion Eveillard, Jacques Delaunay, Hervé Maisonneuve, Nadine Morineau, Bruno Villemagne, Stéphane Vigouroux, François Subiger, Elsa Lestang, Marion Loirat, Anne Parcelier, Pascal Godmer, Mélanie Mercier, Adrien Trebouet, Damien Luque Paz, Ronan Le Calloch, Lenaig Le Clech, Céline Bossard, Anne Moreau, Valérie Ugo, Mathilde Hunault, Philippe Moreau, Steven Le Gouill, Patrice Chevallier, Marie C. Béné, Yannick Le Bris
Published in Haematologica (2020-04-01)Get full text
Article
